Qube Research & Technologies (QRT)’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $24.4M | Sell |
564,216
-196,258
| -26% | -$8.47M | 0.02% | 555 |
|
2025
Q1 | $26.3M | Buy |
760,474
+747,707
| +5,857% | +$25.8M | 0.03% | 455 |
|
2024
Q4 | $350K | Buy |
+12,767
| New | +$350K | ﹤0.01% | 2085 |
|
2024
Q2 | – | Sell |
-2,432
| Closed | -$75.2K | – | 3405 |
|
2024
Q1 | $75.2K | Buy |
2,432
+2,327
| +2,216% | +$72K | ﹤0.01% | 2909 |
|
2023
Q4 | $4.24K | Buy |
+105
| New | +$4.24K | ﹤0.01% | 3308 |
|
2023
Q3 | – | Sell |
-53,473
| Closed | -$920K | – | 3652 |
|
2023
Q2 | $920K | Sell |
53,473
-290,312
| -84% | -$4.99M | ﹤0.01% | 1266 |
|
2023
Q1 | $5.7M | Buy |
343,785
+203,433
| +145% | +$3.37M | 0.02% | 571 |
|
2022
Q4 | $1.07M | Buy |
140,352
+25,397
| +22% | +$194K | 0.01% | 1135 |
|
2022
Q3 | $1.14M | Buy |
+114,955
| New | +$1.14M | 0.01% | 1106 |
|
2022
Q1 | – | Sell |
-16,928
| Closed | -$282K | – | 2430 |
|
2021
Q4 | $282K | Buy |
+16,928
| New | +$282K | ﹤0.01% | 1830 |
|
2021
Q2 | – | Sell |
-23,985
| Closed | -$1.48M | – | 2257 |
|
2021
Q1 | $1.48M | Buy |
+23,985
| New | +$1.48M | 0.02% | 705 |
|
2020
Q4 | – | Sell |
-6,314
| Closed | -$237K | – | 1802 |
|
2020
Q3 | $237K | Sell |
6,314
-6,937
| -52% | -$260K | ﹤0.01% | 1334 |
|
2020
Q2 | $432K | Buy |
+13,251
| New | +$432K | 0.01% | 1175 |
|